Trial Profile
Effects of estradiol/drospirenone on glycoinsulaemic metabolism and other cardiovascular risk factors in postmenopausal women.
Status:
Not stated
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2010
Price :
$35
*
At a glance
- Drugs Estradiol/drospirenone (Primary)
- Indications Menopausal syndrome; Menopause
- Focus Pharmacodynamics
- 09 Nov 2010 New trial record